J Immunother Cancer
Carcinoma, Non-Small-Cell LungDrug-Related Side Effects and Adverse ReactionsImmune Checkpoint Inhibitors
Dr. Rohit Thummalapalli, MD
NPI1003307513PAC ID3476805698
- Medicare services, 2024
- 137
- Medicare patients, 2024
- 36
- Part D claims, 2024
- 102
- Publications
- 27
- MIPS score, 2024
- 80
- Practice address
- 1275 York Avenue, New York, NY 10065
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Thummalapalli's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Rohit Thummalapalli is a hematologist and oncologist in New York, New York
Dr. Thummalapalli practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.
Dr. Thummalapalli's NPI, 1003307513, was assigned on May 21, 2018. Dr. Thummalapalli graduated from Harvard Medical School in 2018. Dr. Thummalapalli holds New York license 311336.
NPI and contact details
- NPI
- 1003307513NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3476805698
- NPI enumeration date
- May 21, 2018
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 34
- Medical school graduation
- 2018
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Rohit Thummalapalli practices at Memorial Sloan Kettering Cancer Center in New York, New York
Dr. Thummalapalli's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.
- Memorial Sloan Kettering Cancer Center1275 York Avenue, New York, NY 10065
Source: Dmand AI Affiliation Data
Dr. Rohit Thummalapalli is affiliated with 5 sites of care and 3 medical groups
Dr. Thummalapalli's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Thummalapalli to 3 more group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.
Memorial Sloan Kettering Cancer Center3 group practices and clinicsNames with a free account2 medical groupsNames with a free account1 home health agencyName with a free account
See all 8 affiliations for Dr. ThummalapalliSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Rohit Thummalapalli's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Thummalapalli practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Memorial Sloan Kettering Cancer Center | Available with a free account |
| +4 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Thummalapalli practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Memorial Sloan Kettering Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Rohit Thummalapalli is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Thummalapalli's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Thummalapalli is board certified in internal medicine by the American Board of Internal Medicine. Dr. Thummalapalli is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Thummalapalli
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
996hematologists and oncologists in New York297hematologists and oncologists in New York90hematologists and oncologists at Memorial Sloan Kettering Cancer Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Rohit Thummalapalli billed Medicare for 137 services in 2024
CMS data shows 137 Medicare services from Dr. Thummalapalli across 2 procedure codes in 2024, all of them office visits, for 36 Medicare patients. Medicare paid $15,095 for them. Every service was in an office.
Medicare services, 2024137
Medicare patients36
Paid by Medicare$15,095
Procedure codes2
Dr. Thummalapalli compared with the New York median for hematologists and oncologists, 2024
- Dr. Thummalapalli
- New York median
- Medicare services
- 137vs 66879% below
- Medicare patients
- 36vs 21083% below
- Part D claims
- 25vs 25890% below
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Thummalapalli's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Thummalapalli?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Thummalapalli and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Rohit Thummalapalli treated 36 Medicare patients in 2024, average age 73
CMS counts 36 Medicare patients who saw Dr. Thummalapalli in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.14, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Thummalapalli's median patient age at 70, with 42% women.
Medicare patients, 202436
Average age73
Average risk score1.14
Dr. Thummalapalli's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Thummalapalli's Medicare patients by sex, 2024
- Women1336%
- Men2364%
Chronic conditions among Dr. Thummalapalli's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer56%
- Diabetes50%
- Arthritis36%
- Anxiety31%
- Atrial fibrillation31%
- Chronic kidney disease31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Thummalapalli's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women42%
- Men57%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Rohit Thummalapalli wrote 102 Medicare Part D claims in 2024
In 2024, Dr. Thummalapalli wrote 102 Medicare Part D claims for 35 patients. 87% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $396 in total drug cost. In 2021, CMS named 161 claims across 8 drugs.
Part D claims, 2024102
Drugs named by CMS2
Total drug cost$396
Part D patients35
Dr. Thummalapalli's Part D claims by kind of drug, 2024
- Generic89 claims87%
- Brand-name13 claims13%
Dr. Thummalapalli's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2024
- 2021
- 2024
- Claims for drugs CMS names
- 2021: 1612024: 2584%
Drugs named by CMS: 2 in 2024, 8 in 2021.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Rohit Thummalapalli scored 80 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Thummalapalli for performance year 2024, reported as part of a group. Dr. Thummalapalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Thummalapalli as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Thummalapalli's MIPS scores, performance year 2024
- 80of 100Final score
- 71.5of 100Quality
- 40of 100Improvement Activities
- 71of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Thummalapalli by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Rohit Thummalapalli has 27 publications on record
Dmand AI links 27 papers to Dr. Thummalapalli, published from 2016 to 2025. 2017 was the busiest year, with 4. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Immune Checkpoint Inhibitors. Dr. Thummalapalli has published most often in Clin Cancer Res. Dr. Thummalapalli's most frequent co-authors are Adam J. Schoenfeld, MD, David A. Barbie, MD and Charles M. Rudin, MD, PhD.
Papers27
Years published2016 to 2025
Dr. Thummalapalli's papers by year, 2016 to 2025
Topics Dr. Thummalapalli writes about most
- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Immune Checkpoint Inhibitors
- Biomarkers, Tumor
- Immunotherapy
- Proto-Oncogene Proteins p21(ras)
- Kelch-Like ECH-Associated Protein 1
- Programmed Cell Death 1 Receptor
Dr. Thummalapalli's most frequent co-authors
- Adam J. Schoenfeld, MD6 shared papers
- David A. Barbie, MD5 shared papers
- Charles M. Rudin, MD, PhD4 shared papers
Recent publications by Dr. Thummalapalli
AllelesBiomarkers, TumorGenes, Tumor Suppressor
Adenocarcinoma, MucinousAdenocarcinoma of LungBiomarkers, Tumor
AcrylamidesAniline CompoundsAntibodies, Monoclonal
See who Dr. Thummalapalli researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Thummalapalli works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Rohit Thummalapalli received $3,142 in industry payments from 2024 to 2025
CMS Open Payments shows 2 general payments to Dr. Thummalapalli from 2 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 96% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $3,010.
General payments to Dr. Thummalapalli by program year, 2024 to 2025
General payments to Dr. Thummalapalli by kind, 2024 to 2025
$3.1Kin total
- Consulting fees$3,01096%
- Food and beverage$1324%
Companies that paid Dr. Thummalapalli the most, 2024 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Rohit Thummalapalli graduated from Harvard Medical School
Dr. Thummalapalli graduated from Harvard Medical School in 2018.
- Medical school
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. Rohit Thummalapalli's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Rohit Thummalapalli
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Rohit Thummalapalli's NPI number?
Dr. Rohit Thummalapalli's NPI number is 1003307513. It was assigned on May 21, 2018, and it is active in the NPI Registry.
What kind of doctor is Dr. Rohit Thummalapalli?
Dr. Rohit Thummalapalli is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Rohit Thummalapalli practice?
Dr. Thummalapalli practices at 1275 York Avenue, New York, NY 10065. Dr. Thummalapalli's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. Dmand AI also links Dr. Thummalapalli to 3 group practices and clinics, 2 medical groups and 1 home health agency.
What is Dr. Rohit Thummalapalli's medical license number?
Dr. Thummalapalli holds New York license 311336.
Which hospitals is Dr. Rohit Thummalapalli affiliated with?
Dr. Thummalapalli practices at Memorial Sloan Kettering Cancer Center in New York, New York.
What medical group is Dr. Rohit Thummalapalli part of?
Dr. Thummalapalli is linked to Memorial Sloan Kettering Cancer Center. Dmand AI links Dr. Thummalapalli to 2 more medical groups.
Does Dr. Rohit Thummalapalli accept Medicare?
Yes. CMS data shows Dr. Thummalapalli billed Medicare for 137 services in 2024, and Dr. Thummalapalli accepts Medicare assignment.
Does Dr. Rohit Thummalapalli offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Thummalapalli as offering telehealth services.
What is Dr. Rohit Thummalapalli's MIPS score?
Dr. Thummalapalli's MIPS final score for performance year 2024 is 80 out of 100, reported as part of a group.
How many Medicare patients does Dr. Rohit Thummalapalli see?
CMS counts 36 Medicare patients who saw Dr. Thummalapalli in 2024, with an average age of 73.
Show 8 more questionsShow fewer questions
Is Dr. Rohit Thummalapalli board certified?
Yes. Dr. Thummalapalli is board certified in internal medicine by the American Board of Internal Medicine.
What services does Dr. Rohit Thummalapalli bill to Medicare?
In 2024, Dr. Thummalapalli's most billed Medicare services were office visit, established patient (99214) and office visit, new patient (99205).
Where did Dr. Rohit Thummalapalli go to medical school?
Dr. Thummalapalli graduated from Harvard Medical School in 2018.
What drugs does Dr. Rohit Thummalapalli prescribe most?
In 2024 Medicare Part D data, Dr. Thummalapalli's most prescribed drugs by claims were Pantoprazole Sodium and Ondansetron ODT.
Has Dr. Rohit Thummalapalli received payments from drug or device companies?
CMS Open Payments shows $3,142 in general payments to Dr. Thummalapalli from 2 companies from 2024 to 2025. The largest total came from Boehringer Ingelheim Pharmaceuticals, Inc.
How long has Dr. Rohit Thummalapalli been practicing?
Dr. Thummalapalli graduated from medical school in 2018, 8 years ago.
Does Dr. Rohit Thummalapalli do research?
Dmand AI links 27 publications to Dr. Thummalapalli, published from 2016 to 2025.
Who does Dr. Rohit Thummalapalli publish with?
Dr. Thummalapalli's most frequent co-authors are Adam J. Schoenfeld, MD (6 shared papers), David A. Barbie, MD (5 shared papers) and Charles M. Rudin, MD, PhD (4 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card